C. Oberhoff
- Hematology top 5%
- Erythropoietin and Anemia Treatment 7
- Blood Coagulation and Thrombosis Mechanisms 5
- Oncology top 10%
- Cancer Treatment and Pharmacology 9
- Cancer Cells and Metastasis 5
- HER2/EGFR in Cancer Research 5
- PARP inhibition in cancer therapy 4
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 5
- Cancer Research top 10%
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
- Co-authors
- S. SeeberJörg BarkhausenStefan G. RuehmChristoph U. HerbornThomas C. LauensteinSusanne C. GoehdeJörg F. DebatinA. E. Schindler
- Cited by
- HematologyOncologyInternal Medicine
- Journals
- Annals of Oncology (5 papers)Breast Cancer Research and Treatment (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
C. Oberhoff
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 82
- Hematology 297
- Oncology 454
- Internal Medicine 42
- Cancer Research 164
- Genetics 104
Countries citing papers authored by C. Oberhoff
This map shows the geographic impact of C. Oberhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Oberhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Oberhoff more than expected).
Fields of papers citing papers by C. Oberhoff
This network shows the impact of papers produced by C. Oberhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Oberhoff. The network helps show where C. Oberhoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Oberhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 10 | |
| 2 | 2013 | 15 | |
| 3 | 2009 | 7 | |
| 4 | 2007 | 3 | |
| 5 | 2005 | 18 | |
| 6 | 2005 | 2 | |
| 7 | 2004 | 56 | |
| 8 | 2004 | 203 | |
| 9 | Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. | 2003 | 66 |
| 10 | 2002 | 36 | |
| 11 | 2002 | 11 | |
| 12 | 2001 | 8 | |
| 13 | 2001 | 11 | |
| 14 | 2001 | 12 | |
| 15 | 2001 | 11 | |
| 16 | 2000 | 22 | |
| 17 | 1999 | 31 | |
| 18 | 1998 | 55 | |
| 19 | 1998 | 14 | |
| 20 | 1998 | 88 |
About C. Oberhoff
C. Oberhoff is a scholar working on Hematology, Internal Medicine and Oncology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Erythropoietin and Anemia Treatment (7 papers), Cancer Cells and Metastasis (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), HER2/EGFR in Cancer Research (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Hematology (297 citations), Oncology (454 citations) and Internal Medicine (42 citations). C. Oberhoff has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include S. Seeber, Jörg Barkhausen, Stefan G. Ruehm, Christoph U. Herborn, Thomas C. Lauenstein, Susanne C. Goehde, Jörg F. Debatin, A. E. Schindler, Ulrich Winkler and M. E. Scheulen. Their work appears in journals such as Annals of Oncology, Breast Cancer Research and Treatment, Cancer Chemotherapy and Pharmacology, Archives of Gynecology and Obstetrics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.